Linagliptin 2.5 mg

Introduction

Linagliptin 2.5 mg is a DPP-4 inhibitor class oral antidiabetic medicine designed to improve blood sugar control in adults with type 2 diabetes mellitus. It enhances the body's natural ability to regulate glucose by increasing insulin release and reducing glucagon levels after meals. LINALIGLIP 2.5 by Steris Healthcare Pvt Ltd is a high-quality formulation trusted for its safety, convenience, and efficacy. Ideal for use in combination therapies, this dose is often included in fixed-dose combinations with metformin or SGLT2 inhibitors, or prescribed where a lower starting dose is preferred.

What is Linagliptin 2.5 mg?

Linagliptin 2.5 mg tablet is part of a class of medications called Dipeptidyl Peptidase-4 (DPP-4) inhibitors. It helps in controlling postprandial and fasting blood glucose levels by enhancing incretin activity. LINALIGLIP 2.5 is often prescribed either as part of dual therapy or in patients with renal or hepatic dysfunction, where other antidiabetics may not be suitable.

Linagliptin 2.5 mg Uses

LINALIGLIP 2.5 is used in the management of:

• Type 2 Diabetes Mellitus in adults

• Patients who require lower initial dosing

• Patients with moderate to severe renal impairment

• Combination treatment with metformin, SGLT2 inhibitors, or insulin

Not suitable for Type 1 diabetes or diabetic ketoacidosis.

Mechanism of Action

Linagliptin works by inhibiting the DPP-4 enzyme, which degrades incretin hormones like GLP-1 and GIP. Increased incretin levels:

• Stimulate insulin release from pancreatic β-cells

• Suppress glucagon secretion from α-cells

• Help maintain better glucose homeostasis post meals

Dosage and Administration

• Standard dosage: Linagliptin 2.5 mg once daily

• Can be taken with or without food

• Dose adjustment not required for renal or hepatic impairment

• Often used as part of combination therapy

Always follow the doctor’s prescribed regimen and timing.

Benefits of LINALIGLIP 2.5 (Linagliptin 2.5 mg Tablet)

• Weight-neutral and safe for long-term use

• Low risk of hypoglycemia

• Once-daily dosing improves compliance

• Safe in renal and hepatic dysfunction

• Suitable for elderly and comorbid patients

• Manufactured under WHO-GMP certified standards

Side Effects of Linagliptin 2.5 mg

Most patients tolerate linagliptin well. However, possible side effects may include:

• Upper respiratory tract infection

• Cough

• Joint pain

• Headache

• Diarrhea

Rare but serious:

• Pancreatitis

• Severe allergic reactions

• Skin blistering disorders (bullous pemphigoid)

Report any unusual symptoms to your healthcare provider immediately.

Precautions & Warnings

• Not recommended in Type 1 diabetes or ketoacidosis

• Caution in patients with pancreatitis history

• Avoid in pregnancy and lactation unless advised

• Periodic monitoring of blood glucose and HbA1c is necessary

Drug Interactions

• Rifampicin may reduce linagliptin levels

• Caution when used with insulin or sulfonylureas due to potential hypoglycemia

• Minimal interaction with other oral antidiabetic agents

Linagliptin 2.5 mg Price in India

The linagliptin 2.5 mg price can vary depending on the region and brand. LINALIGLIP 2.5 by Steris Healthcare offers a cost-effective solution without compromising on quality. It is readily available through authorized distributors and stockists across India.

To inquire about bulk pricing or MRP, contact Steris Healthcare’s sales team.

Why Choose LINALIGLIP 2.5 from Steris Healthcare Pvt Ltd?

• Manufactured in WHO-GMP certified facilities

• Complies with stringent quality and safety standards

• Backed by Steris Healthcare’s reputation in chronic care solutions

• Economical and clinically effective

• Available with pan-India distribution support

FAQs – Linagliptin 2.5 mg Tablet (LINALIGLIP 2.5)

Q1: What is linagliptin 2.5 mg used for?

A: It is used to manage type 2 diabetes mellitus and control blood sugar levels effectively.

Q2: Can I take LINALIGLIP 2.5 with metformin?

A: Yes, it is often prescribed in combination with metformin or other antidiabetics.

Q3: Does linagliptin cause weight gain?

A: No, it is considered weight-neutral.

Q4: Is linagliptin 2.5 mg safe for kidney patients?

A: Yes, it is safe for patients with kidney disease and does not require dose adjustment.

Q5: How should I take this tablet?

A: Once daily, with or without food, at the same time each day.

Conclusion

LINALIGLIP 2.5, containing linagliptin 2.5 mg, is a trusted and clinically effective option for type 2 diabetes management. It’s especially useful for patients with renal impairment or those starting combination therapy. Backed by the quality assurance of Steris Healthcare Pvt Ltd, it offers excellent glycemic control with long-term safety and affordability.